You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small cell lung cancer, Durvalumab

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Iowa City, Iowa
    University of Iowa
Oct 10, 2023

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

NSCLC Trial in Tampa, Philadelphia (Durvalumab, Carboplatin, Abequolixron)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tampa, Florida
  • +1 more
Jun 9, 2023

NSCLC, Small Cell Lung Cancer Trial in Worldwide (Durvalumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Houston, Texas
  • +7 more
Feb 1, 2023

Durvalumab in Combination With Standard Chemotherapy of

Recruiting
  • Small-cell Lung Cancer
  • Extensive-stage Small-cell Lung Cancer
    • Néo Fáliro, Greece
      Metropolitan Hospital
    Mar 7, 2023

    NSCLC Trial (Durvalumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jun 22, 2023

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

    Not yet recruiting
    • Small Cell Lung Cancer
    • +2 more
    • Association of lurbinectedin and durvalumab
    • Association of carboplatin and etoposide
    • Bordeaux, France
      Institut Bergonié
    Oct 5, 2022

    Small Cell Lung Cancer Trial in Seoul (Durvalumab)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Nov 6, 2022

    Outcomes ofBrazilian Cohort of Previously Untreated Extensive

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Observational study
    • (no location specified)
    Aug 24, 2023

    Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Stage III Non-small-cell Lung Cancer
    • Durvalumab
    • +4 more
    • Chicago, Illinois
    • +3 more
    Jan 18, 2023

    Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Stage III Lung Cancer AJCC v8
    • Durvalumab
    • Radiation Therapy
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

    Recruiting
    • Platinum-Resistant Lung Small Cell Carcinoma
    • +3 more
    • Durvalumab
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023

    Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

    Not yet recruiting
    • Nonsmall Cell Lung Cancer Stage III
    • Unresectable Non-Small Cell Lung Carcinoma
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 12, 2023

    NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

    Not yet recruiting
    • Non-small Cell Lung Cancer Stage III
    • radiotherapy
    • +3 more
    • (no location specified)
    Sep 10, 2023

    NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Aug 17, 2023

    Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)

    Not yet recruiting
    • Lung Cancer
    • Gastro-intestinal Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    May 9, 2023

    Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • Durvalumab + carboplatin/cisplatin + etoposide
    • +2 more
    • (no location specified)
    Aug 3, 2022

    Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Durvalumab 50 MG/1 ML Intravenous Solution
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Oct 31, 2022

    Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)

    Not yet recruiting
    • Small-cell Lung Cancer
    • +2 more
    • Ablative Radiation
    • +3 more
    • (no location specified)
    Mar 11, 2022

    Advanced or Metastatic NSCLC Trial in Moscow, Saint Petersburg, St. Petersburg (Ceralasertib, Durvalumab)

    Recruiting
    • Advanced or Metastatic NSCLC
    • Moscow, Russian Federation
    • +7 more
    Jul 4, 2023

    Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • carboplatin chemotherapy
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Nov 3, 2023

    EvaluatioN of durvALumab Utilization and Effectiveness for First

    Recruiting
    • Small Cell Lung Carcinoma
    • Angers, France
    • +24 more
    Jan 12, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

    Recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • +3 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 10, 2022

    Non-small-cell Lung Cancer Patients Trial in Roma (Durvalumab, Olaparib tablet, Single-agent chemo)

    Recruiting
    • Non-small-cell Lung Cancer Patients
    • Roma, RM, Italy
      Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
    Sep 30, 2022